Oxidative and non-oxidative DNA damage and cardiovascular disease

Free Radical Research

Volumn 46, Issue 4, 2012, Pages 554-564

  Malik, Qudsia ^a   Herbert, Karl E ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

ApoE ; Atherosclerosis; Coronary artery disease; Mitochondria; Reactive oxygen species

Indexed keywords

ANGIOTENSIN II; ARSENIC; BIOLOGICAL MARKER; CADMIUM; CELL NUCLEUS DNA; GLUCOSE; MITOCHONDRIAL DNA;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE COURSE; DNA DAMAGE; ENVIRONMENTAL FACTOR; HUMAN; NONHUMAN; OXIDATIVE STRESS; REVIEW; RISK FACTOR;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; DNA; DNA DAMAGE; HUMANS;

EID: 84858129800     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2012.663913     Document Type: Review

References (72)

1. Masetti S, Botto N, Manfredi S, Colombo MG, Rizza A, Vassalle C, et al. Interactive effect of the glutathione S-transferase genes and cigarette smoking on occurrence and severity of coronary artery risk. J Mol Med 2003;81:488-494. (Pubitemid 37070201)
2. Nair J, De Flora S, Izzotti A, Bartsch H. Lipid peroxidationderived etheno-DNA adducts in human atherosclerotic lesions. Mutat Res 2007;621:95-105. (Pubitemid 47042074)
3. von Sonntag C. New aspects in the free-radical chemistry of pyrimidine nucleobases. Free Radic Res Commun 1987;2: 217-224.
4. Cooke MS, Evans MD, Dizdaroglu M, Lunec J. Oxidative DNA damage: Mechanisms, mutation, and disease. FASEB J 2003;17:1195-1214. (Pubitemid 36775767)
5. Melvin T, Bothe E, Schulte-Frohlinde D. The reaction of triplet 2-methyl-1,4-naphthoquinone (menadione) with DNA and polynucleotides. Photochem Photobiol 1996;64: 769-776.
6. Toyokuni S, Okamoto K, Yodoi J, Hiai H. Persistent oxidative stress in cancer. FEBS Lett 1995;358:1-3.
7. Croteau DL, Bohr VA. Repair of oxidative damage to nuclear and mitochondrial DNA in mammalian cells. J Biol Chem 1997;272:25409-25412. (Pubitemid 27438839)
8. Costa RA, Romagna CD, Pereira JL, Souza-Pinto NC. The role of mitochondrial DNA damage in the citotoxicity of reactive oxygen species. J Bioenerg Biomembr 2011;43: 25-29.
9. Spelbrink JN. Functional organization of mammalian mitochondrial DNA in nucleoids: History, recent developments, and future challenges. IUBMB Life 2010;62:19-32.
10. Richter C, Park JW, Ames BN. Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc Natl Acad Sci USA 1988;85:6465-6467.
11. Trapp C, McCullough AK, Epe B. The basal levels of 8-oxoG and other oxidative modifi cations in intact mitochondrial DNA are low even in repair-defi cient (Ogg1(-/-)/Csb(-/-)) mice. Mutat Res 2007;625:155-163. (Pubitemid 350016114)
12. Gredilla R, Bohr VA, Stevnsner T. Mitochondrial DNA repair and association with aging-an update. Exp Gerontol 2010;45:478-488.
13. Kaneto H, Fujii J, Myint T, Miyazawa N, Islam KN, Kawasaki Y, et al. Reducing sugars trigger oxidative modifi cation and apoptosis in pancreatic beta-cells by provoking oxidative stress through the glycation reaction. Biochem J 1996; 320:855-863. (Pubitemid 27013801)
14. Farhangkhoee H, Khan ZA, Barbin Y, Chakrabarti S. Glucose-induced up-regulation of CD36 mediates oxidative stress and microvascular endothelial cell dysfunction. Diabetologia 2005;48:1401-1410. (Pubitemid 41186108)
15. Quagliaro L, Piconi L, Assaloni R, Da Ros R, Maier A, Zuodar G, et al. Intermittent high glucose enhances ICAM-1, VCAM-1 and E-selectin expression in human umbilical vein endothelial cells in culture: The distinct role of protein kinase C and mitochondrial superoxide production. Atherosclerosis 2005;183:259-267. (Pubitemid 41579276)
16. Du XL, Edelstein D, Dimmeler S, Ju Q, Sui C, Brownlee M, et al. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modifi cation at the akt site. J Clin Invest 2001;108:1341-1348. (Pubitemid 33107762)
17. Madsen-Bouterse SA, Zhong Q, Mohammad G, Ho YS, Kowluru RA. Oxidative damage of mitochondrial DNA in diabetes and its protection by manganese superoxide dismutase. Free Radic Res 2010;44:313-321.
18. Medikayala S, Piteo B, Zhao X, Edwards JG. Chronically elevated glucose compromises myocardial mitochondrial DNA integrity by alteration of mitochondrial topoisomerase function. Am J Physiol Cell Physiol 2011;300: C338-C348.
19. Li TK, Chen AY, Yu C, Mao Y, Wang H, Liu LF, et al. Activation of topoisomerase II-mediated excision of chromosomal DNA loops during oxidative stress. Genes Dev 1999;13:1553-1560. (Pubitemid 29297923)
20. Sun J, Xu Y, Sun S, Sun Y, Wang X. Intermittent high glucose enhances cell proliferation and VEGF expression in retinal endothelial cells: The role of mitochondrial reactive oxygen species. Mol Cell Biochem 2010;343:27-35.
21. Mehta PK, Griendling KK. Angiotensin II cell signaling: Physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 2007;292:C82-C97. (Pubitemid 46127306)
22. Mazza F, Goodman A, Lombardo G, Vanella A, Abraham NG. Heme oxygenase-1 gene expression attenuates angiotensin II-mediated DNA damage in endothelial cells. Exp Biol Med 2003;228:576-583. (Pubitemid 37203681)
23. Herbert KE, Mistry Y, Hastings R, Poolman T, Niklason L, Williams B, et al. Angiotensin II-mediated oxidative DNA damage accelerates cellular senescence in cultured human vascular smooth muscle cells via telomeredependent and independent pathways. Circ Res 2008; 102:201-208. (Pubitemid 351651124)
24. Schupp N, Schmid U, Rutkowski P, Lakner U, Kanase N, Heidland A, et al. Angiotensin II-induced genomic damage in renal cells can be prevented by angiotensin II type 1 receptor blockage or radical scavenging. Am J Physiol Renal Physiol 2007;292:F1427-F1434. (Pubitemid 46701870)
25. Liu Q, Wang G, Zhou G, Tan Y, Wang X, Wei W, et al. Angiotensin II-induced p53-dependent cardiac apoptotic cell death: Its prevention by metallothionein. Toxicol Lett 2009;191:314-320.
26. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 1998;273: 5858-5868. (Pubitemid 28124064)
27. Suematsu N, Tsutsui H, Wen J, Kang D, Ikeuchi M, Ide T, et al. Oxidative stress mediates tumor necrosis factor-alphainduced mitochondrial DNA damage and dysfunction in cardiac myocytes. Circulation 2003;107:1418-1423. (Pubitemid 36350742)
28. Bhatnagar A. Environmental cardiology: Studying mechanistic links between pollution and heart disease. Circ Res 2006;99:692-705. (Pubitemid 44498303)
29. Tellez-Plaza M, Navas-Acien A, Crainiceanu CM, Guallar E. Cadmium exposure and hypertension in the 1999-2004 national health and nutrition examination survey (NHANES). Environ Health Perspect 2008;116:51-56.
30. Houtman JP. Prolonged low-level cadmium intake and atherosclerosis. Sci Total Environ 1993;138:31-36.
31. Messner B, Knofl ach M, Seubert A, Ritsch A, Pfaller K, Henderson B, et al. Cadmium is a novel and independent risk factor for early atherosclerosis mechanisms and in vivo relevance. Arterioscler Thromb Vasc Biol 2009;29: 1392-1398.
32. Yang MS, Li D, Lin T, Zheng JJ, Zheng W, Qu JY, et al. Increase in intracellular free/bound NAD[P]H as a cause of cd-induced oxidative stress in the HepG(2) cells. Toxicology 2008;247:6-10.
33. Pathak N, Khandelwal S. Impact of cadmium in T lymphocyte subsets and cytokine expression: Differential regulation by oxidative stress and apoptosis. Biometals 2008;21:179-187. (Pubitemid 351421986)
34. Liu F, Jan KY. DNA damage in arsenite-and cadmiumtreated bovine aortic endothelial cells. Free Radic Biol Med 2000;28:55-63. (Pubitemid 30045573)
35. Lynn S, Gurr JR, Lai HT, Jan KY. NADH oxidase activation is involved in arsenite-induced oxidative DNA damage in human vascular smooth muscle cells. Circ Res 2000;86: 514-519. (Pubitemid 30165042)
36. Martinet W, Knaapen MW, De Meyer GR, Herman AG, Kockx MM. Oxidative DNA damage and repair in experimental atherosclerosis are reversed by dietary lipid lowering. Circ Res 2001;88:733-739. (Pubitemid 32378144)
37. Oumouna-Benachour K, Hans CP, Suzuki Y, Naura A, Datta R, Belmadani S, et al. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-defi cient mice: Effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death. Circulation 2007;115:2442-2450. (Pubitemid 46717967)
38. Shall S. The function of poly (ADP-ribosylation) in DNA breakage and rejoining. Mol Cell Biochem 1994;138:7175.
39. Folkmann JK, Loft S, Moller P. Oxidatively damaged DNA in aging dyslipidemic ApoE-/-and wild-type mice. Mutagenesis 2007;22:105-110. (Pubitemid 46364515)
40. Godschalk RW, Albrecht C, Curfs DM, Schins RP, Bartsch H, van Schooten FJ, et al. Decreased levels of lipid peroxidation-induced DNA damage in the onset of atherogenesis in apolipoprotein E defi cient mice. Mutat Res 2007;621: 87-94. (Pubitemid 47042073)
41. Cakir Y, Yang Z, Knight CA, Pompilius M, Westbrook D, Bailey SM, et al. Effect of alcohol and tobacco smoke on mtDNA damage and atherogenesis. Free Radic Biol Med 2007;43:1279-1288. (Pubitemid 47429938)
42. Chuang GC, Yang Z, Westbrook DG, Pompilius M, Ballinger CA, White CR, et al. Pulmonary ozone exposure induces vascular dysfunction, mitochondrial damage, and atherogenesis. Am J Physiol Lung Cell Mol Physiol 2009;297: L209-L216.
43. Kang GS, Gillespie PA, Gunnison A, Moreira AL, Tchou-Wong KM, Chen LC, et al. Long-term inhalation exposure to nickel nanoparticles exacerbated atherosclerosis in a susceptible mouse model. Environ Health Perspect 2011; 119:176-181.
44. Andreassi MG. DNA damage, vascular senescence and atherosclerosis. J Mol Med 2008;86:1033-1043.
45. Costopoulos C, Liew TV, Bennett M. Ageing and atherosclerosis: Mechanisms and therapeutic options. Biochem Pharmacol 2008;75:1251-1261. (Pubitemid 351313894)
46. Khan SJ, Pham S, Wei Y, Mateo D, St-Pierre M, Fletcher TM, et al. Stress-induced senescence exaggerates postinjury neointimal formation in the old vasculature. Am J Physiol Heart Circ Physiol 2010;298:H66-H74.
47. Mercer JR, Cheng KK, Figg N, Gorenne I, Mahmoudi M, Griffi n J, et al. DNA damage links mitochondrial dysfunction to atherosclerosis and the metabolic syndrome. Circ Res 2010;107:1021-1031.
48. De Flora S, Izzotti A, Randerath K, Randerath E, Bartsch H, Nair J, et al. DNA adducts and chronic degenerative disease. pathogenetic relevance and implications in preventive medicine. Mutat Res 1996;366:197-238. (Pubitemid 27051417)
49. De Flora S, Izzotti A, Walsh D, Degan P, Petrilli GL, Lewtas J, et al. Molecular epidemiology of atherosclerosis. FASEB J 1997;11:1021-1031. (Pubitemid 27425904)
50. Izzotti A, De Flora S, Petrilli GL, Gallagher J, Rojas M, Alexandrov K, et al. Cancer biomarkers in human atherosclerotic lesions: Detection of DNA adducts. Cancer Epidemiol Biomarkers Prev 1995;4:105-110.
51. Zhang YJ, Weksler BB, Wang L, Schwartz J, Santella RM. Immunohistochemical detection of polycyclic aromatic hydrocarbon-DNA damage in human blood vessels of smokers and non-smokers. Atherosclerosis 1998;140:325-331. (Pubitemid 28535323)
52. Binkova B, Smerhovsky Z, Strejc P, Boubelik O, Stavkova Z, Chvatalova I, et al. DNA-adducts and atherosclerosis: A study of accidental and sudden death males in the czech republic. Mutat Res 2002;501:115-128. (Pubitemid 34270656)
53. Leadon SA, Stampfer MR, Bartley J. Production of oxidative DNA damage during the metabolic activation of benzo[a] pyrene in human mammary epithelial cells correlates with cell killing. Proc Natl Acad Sci USA 1988;85:4365-4368.
54. Gur M, Yilmaz R, Demirbag R, Yildiz A, Kocyigit A, Celik H, et al. Lymphocyte DNA damage is associated with increased aortic intima-media thickness. Mutat Res 2007;617:111-118. (Pubitemid 46386093)
55. Pernice F, Floccari F, Caccamo C, Belghity N, Mantuano S, Pacile ME, et al. Chromosomal damage and atherosclerosis. A protective effect from simvastatin. Eur J Pharmacol 2006;532:223-229.
56. Botto N, Rizza A, Colombo MG, Mazzone AM, Manfredi S, Masetti S, et al. Evidence for DNA damage in patients with coronary artery disease. Mutat Res 2001;493:23-30. (Pubitemid 32539427)
57. Andreassi MG, Botto N, Cocci F, Battaglia D, Antonioli E, Masetti S, et al. Methylenetetrahydrofolate reductase gene C677T polymorphism, homocysteine, vitamin B12, and DNA damage in coronary artery disease. Hum Genet 2003;112:171-177. (Pubitemid 36869100)
58. Shen YH, Utama B, Wang J, Raveendran M, Senthil D, Waldman WJ, et al. Human cytomegalovirus causes endothelial injury through the ataxia telangiectasia mutant and p53 DNA damage signaling pathways. Circ Res 2004;94: 1310-1317. (Pubitemid 38724476)
59. Martinet W, Knaapen MW, De Meyer GR, Herman AG, Kockx MM. Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation 2002;106:927-932. (Pubitemid 34925325)
60. Botto N, Masetti S, Petrozzi L, Vassalle C, Manfredi S, Biagini A, et al. Elevated levels of oxidative DNA damage in patients with coronary artery disease. Coron Artery Dis 2002;13:269-274. (Pubitemid 35397528)
61. Izzotti A, Piana A, Minniti G, Vercelli M, Perrone L, De Flora S, et al. Survival of atherosclerotic patients as related to oxidative stress and gene polymorphisms. Mutat Res 2007;621:119-128. (Pubitemid 47042077)
62. Izzotti A, Cartiglia C, Lewtas J, De Flora S. Increased DNA alterations in atherosclerotic lesions of individuals lacking the GSTM1 genotype. FASEB J 2001;15:752-757. (Pubitemid 32245993)
63. Satoh M, Ishikawa Y, Takahashi Y, Itoh T, Minami Y, Nakamura M, et al. Association between oxidative DNA damage and telomere shortening in circulating endothelial progenitor cells obtained from metabolic syndrome patients with coronary artery disease. Atherosclerosis 2008;198: 347-353. (Pubitemid 351707385)
64. Martinet W, de Meyer GR, Herman AG, Kockx MM. Reactive oxygen species induce RNA damage in human atherosclerosis. Eur J Clin Invest 2004;34:323-327. (Pubitemid 38748071)
65. Ballinger SW, Patterson C, Knight-Lozano CA, Burow DL, Conklin CA, Hu Z, et al. Mitochondrial integrity and function in atherogenesis. Circulation 2002;106:544-549. (Pubitemid 34827702)
66. Meissner C, Bruse P, Mohamed SA, Schulz A, Warnk H, Storm T, et al. The 4977 bp deletion of mitochondrial DNA in human skeletal muscle, heart and different areas of the brain: A useful biomarker or more? Exp Gerontol 2008;43:645-652.
67. Wei YH. Mitochondrial DNA alterations as ageing-associated molecular events. Mutat Res 1992;275:145-155.
68. Corral-Debrinski M, Shoffner JM, Lott MT, Wallace DC. Association of mitochondrial DNA damage with aging and coronary atherosclerotic heart disease. Mutat Res 1992; 275:169-180.
69. Lai LP, Tsai CC, Su MJ, Lin JL, Chen YS, Tseng YZ, et al. Atrial fi brillation is associated with accumulation of aging-related common type mitochondrial DNA deletion mutation in human atrial tissue. Chest 2003;123: 539-544.
70. Lin PH, Lee SH, Su CP, Wei YH. Oxidative damage to mitochondrial DNA in atrial muscle of patients with atrial fi brillation. Free Radic Biol Med 2003;35:1310-1318.
71. Bogliolo M, Izzotti A, De Flora S, Carli C, Abbondandolo A, Degan P, et al. Detection of the ' 4977 bp ' mitochondrial DNA deletion in human atherosclerotic lesions. Mutagenesis 1999;14:77-82. (Pubitemid 29048245)
72. Botto N, Berti S, Manfredi S, Al-Jabri A, Federici C, Clerico A, et al. Detection of mtDNA with 4977 bp deletion in blood cells and atherosclerotic lesions of patients with coronary artery disease. Mutat Res 2005; 570:81-88. (Pubitemid 40179270)